Burgelman (2021) Scholarly publishing needs regulation | Research Professional News

Creeping oligopoly threatens value, innovation and the flow of knowledge, says Jean-Claude Burgelman The world of scientific communication has changed significantly over the past 12 months. Understandably, the amazing mobilisation of research and scholarly publishing in an effort to mitigate the effects of Covid-19 and find a vaccine has overshadowed everything else. But two other less-noticed events could also have profound implications for the industry and the researchers who rely on it. On 10 January 2020, Taylor and Francis announced its acquisition of one of the most innovative small open-access publishers, F1000 Research. A year later, on 5 January 2021, another of the big commercial scholarly publishers, Wiley, paid nearly $300 million for Hindawi, a significant open-access publisher in London. These acquisitions come alongside rapid change in publishers’ functions and business models. Scientific publishing is no longer only about publishing articles. It’s a knowledge industry—and it’s increasingly clear it needs to be regulated like one. The two giant incumbents, Springer Nature and Elsevier, are already a long way down the road to open access, and have built up impressive in-house capacity. But Wiley, and Taylor and Francis, had not. That’s why they decided to buy young open-access publishers. Buying up a smaller, innovative competitor is a well-established way for an incumbent in any industry to expand its reach, gain the ability to do new things and reinvent its business model—it’s why Facebook bought WhatsApp and Instagram, for example. [...]